We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YXT:NASDAQYXT.COM GROUP HOLDING LIMITED - American Depository Shares Analysis

Data as of 2026-09-01 - not real-time

$2.54

Latest Price

9/10Risk

Risk Level: High

Executive Summary

YXT.COM Group Holding Limited trades at $2.54, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Over a rolling month the price has lost 21.4%. RSI sits at 44.9, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $2.54 and resistance at $32.14.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Revenue is growing at 6.0% on a -28.5% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 749.6%, a beta of -1.76 and a maximum drawdown of 89.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to sell, carrying 4/10 conviction.

Top Market Events

SUZHOU, China, Aug. 14, 2026 GLOBE NEWSWIRE -- YXT.COM GROUP HOLDING Ltd NASDAQ: YXT "YXT.com" or the "Company" , a...SUZHOU, China, Aug. 13, 2026 GLOBE NEWSWIRE -- YXT.com Group Holding Limited NASDAQ: YXT “YXT.com” or the...YXT To Announce Financial Results For The First Six Months Of 2026 On August 13, 2026.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 5.64
  • MACD momentum is negative
  • 30-day price change of -21.4%

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 5.64
  • 30-day volatility of 749.6%
  • MACD momentum is negative

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Negative profit margin of -28.5%
  • Negative return on equity of -89.4%
  • Elevated debt-to-equity of 203

Key Metrics & Analysis

Financial Health

Revenue Growth6.00%
Profit Margin-28.47%
P/E Ratio-24.4
ROE-89.39%
ROA-10.31%
Debt/Equity202.67
P/B Ratio1.4
Op. Cash Flow$-85899000
Free Cash Flow$52.5M
Industry P/E35.2

Technical Analysis

TrendNeutral
RSI44.9
Support$2.54
Resistance$32.14
MA 20$4.86
MA 50$3.98
MA 200$5.64
MACDBearish
VolumeDecreasing
Fear & Greed Index93.16

Valuation

Fair Value$116.22
GradeFair
TypeBlend

Risk Assessment

Beta-1.76
Volatility749.56%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.